China’s Rise in Drug Development Challenges U.S. Dominance
Key Chinese companies, such as WuXi AppTec and BeiGene, have made substantial investments in research and development, leading to a surge in new drug approvals. In 2021 alone, the National Medical Products Administration (NMPA) approved a record 60 new drugs, a stark contrast to the slower pace of approvals seen in the United States during … Read more